These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 21765214)

  • 1. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway.
    Shibata S; Mu S; Kawarazaki H; Muraoka K; Ishizawa K; Yoshida S; Kawarazaki W; Takeuchi M; Ayuzawa N; Miyoshi J; Takai Y; Ishikawa A; Shimosawa T; Ando K; Nagase M; Fujita T
    J Clin Invest; 2011 Aug; 121(8):3233-43. PubMed ID: 21765214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome.
    Fujita T
    Hypertension; 2010 Apr; 55(4):813-8. PubMed ID: 20176994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.
    Nagase M
    Clin Exp Nephrol; 2010 Aug; 14(4):303-14. PubMed ID: 20533072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway.
    Mao J; Zhang X; Wang C; Peng S
    Clin Exp Hypertens; 2024 Dec; 46(1):2402258. PubMed ID: 39277848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid receptor activation as an etiological factor in kidney diseases.
    Ueda K; Nagase M
    Clin Exp Nephrol; 2014 Feb; 18(1):16-23. PubMed ID: 23832326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Rac1 GTPase in salt-sensitive hypertension.
    Nagase M
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):148-55. PubMed ID: 23377658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.
    Kawarazaki W; Nagase M; Yoshida S; Takeuchi M; Ishizawa K; Ayuzawa N; Ueda K; Fujita T
    J Am Soc Nephrol; 2012 Jun; 23(6):997-1007. PubMed ID: 22440899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor--Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats.
    Kawarazaki H; Ando K; Shibata S; Muraoka K; Fujita M; Kawarasaki C; Fujita T
    J Hypertens; 2012 Oct; 30(10):1977-85. PubMed ID: 22914542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats.
    Huang BS; White RA; Jeng AY; Leenen FH
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R994-R1000. PubMed ID: 19118098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
    Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mineralocorticoid action in the brain in salt-sensitive hypertension.
    Oki K; Gomez-Sanchez EP; Gomez-Sanchez CE
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):90-5. PubMed ID: 21585422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Rho GDP dissociation inhibitor α in control of epithelial sodium channel (ENaC)-mediated sodium reabsorption.
    Pavlov TS; Levchenko V; Staruschenko A
    J Biol Chem; 2014 Oct; 289(41):28651-9. PubMed ID: 25164814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease.
    Shibata S; Nagase M; Yoshida S; Kawarazaki W; Kurihara H; Tanaka H; Miyoshi J; Takai Y; Fujita T
    Nat Med; 2008 Dec; 14(12):1370-6. PubMed ID: 19029984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGI
    Hirohama D; Kawarazaki W; Nishimoto M; Ayuzawa N; Marumo T; Shibata S; Fujita T
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats.
    Kitada K; Nakano D; Liu Y; Fujisawa Y; Hitomi H; Shibayama Y; Shibata H; Nagai Y; Mori H; Masaki T; Kobori H; Nishiyama A
    PLoS One; 2012; 7(7):e41896. PubMed ID: 22911865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
    Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl rats.
    Manger WM; Simchon S; Stokes MB; Reidy JJ; Kumar AR; Baer L; Gallo G; Haddy FJ
    J Hypertens; 2009 Mar; 27(3):587-98. PubMed ID: 19330919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways.
    Nishimoto M; Fujita T
    Am J Physiol Renal Physiol; 2015 Mar; 308(5):F377-87. PubMed ID: 25520008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of salt sensitivity hypertension.
    Ando K; Fujita T
    Ann Med; 2012 Jun; 44 Suppl 1():S119-26. PubMed ID: 22713140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.